Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-25 Purchase | 2025-03-27 4:37 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 675,000 | $0.6925 | $467,438 | 3,669,054 (Indirect Direct) | View |
| 2025-03-20 Purchase | 2025-03-24 5:03 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 20,416 | $0.73028 | $14,909 | 2,994,054 (Indirect Direct) | View |
| 2025-03-14 Purchase | 2025-03-18 4:27 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 39,105 | $0.75335 | $29,460 | 2,973,638 (Indirect Direct) | View |
| 2025-03-12 Purchase | 2025-03-14 08:02 am | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 97,500 | $0.71348 | $69,564 | 2,934,533 (Indirect Direct) | View |
| 2024-12-31 Purchase | 2025-01-03 07:41 am | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 5,000 | $1.2087 | $6,044 | 2,837,033 (Indirect Direct) | View |
| 2024-12-30 Purchase | 2025-01-02 4:09 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 10,000 | $1.2 | $12,000 | 2,832,043 (Indirect Direct) | View |
| 2024-12-18 Purchase | 2024-12-20 07:33 am | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 106,888 | $0.92925 | $99,326 | 2,822,043 (Indirect Direct) | View |
| 2023-05-24 Purchase | 2023-05-26 4:20 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 1,900 | $5.1528 | $9,790 | 2,715,145 (Indirect Direct) | View |
| 2023-05-23 Purchase | 2023-05-25 4:03 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 11,856 | $5.63 | $66,749 | 2,713,245 (Indirect Direct) | View |
| 2022-12-20 Purchase | 2022-12-21 4:08 pm | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 19,188 | $5.1306 | $98,446 | 2,701,389 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-04 Option Award | 2025-02-05 4:30 pm | N/A 2035-02-04 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 496,000 | $0 | 496,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-04 5:59 pm | N/A 2034-02-28 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 425,000 | $0 | 425,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:07 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 330,000 | $0 | 330,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:09 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna CEO | 327,900 | $0 | 327,900 (Direct) | View |
| 2021-12-13 Option Award | 2021-12-14 5:36 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Vaddi Krishna President, CEO | 8,000 | $12.13 | 2,580,722 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-22 6:16 pm | N/A 2031-07-19 | Prelude Therapeutics Inc | PRLD | Vaddi Krishna President, CEO | 285,800 | $0 | 285,800 (Direct) | View |
| 2020-09-29 Conversion | 2020-09-29 8:06 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Vaddi Krishna President, CEO | 167,229 | $0 | 2,020,948 (Indirect) | View |
Ownership | 2020-09-24 7:30 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Vaddi Krishna President, CEO | 0 | $0 | 4,553,094 (Direct) | View |